| Dennis Kobylarz Md Pc | |
|
10 Granite Avenue Canaan CT 06018-0970 | |
| (860) 824-0753 | |
| (860) 824-4448 |
| Full Name | Dennis Kobylarz Md Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 10 Granite Avenue, Canaan, Connecticut |
| Authorized Official Name and Position | Dennis Kobylarz (PRESIDENT) |
| Authorized Official Contact | 8608240753 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Kobylarz Md Pc Po Box 970 Canaan CT 06018-0970 Ph: (860) 824-0753 | Dennis Kobylarz Md Pc 10 Granite Avenue Canaan CT 06018-0970 Ph: (860) 824-0753 |
| NPI Number | 1437383510 |
|---|---|
| Provider Enumeration Date | 05/05/2009 |
| Last Update Date | 09/29/2010 |
| Medicare PECOS PAC ID | 1759437452 |
|---|---|
| Medicare Enrollment ID | O20090922000442 |
News Archive
The seventh meeting in the "Emergence and Convergence" series jointly organized by La Fondation IPSEN and Nature brings together today in San Antonio (Texas, USA) leading experts to discuss concepts emerging from gene regulation studies in immune cells that have led to insights into the initiation and maintenance of epigenetic chromatin marks necessary for proper differentiation and function of these cells in the immune system.
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIR™. Kiadis Pharma's lead program, ATIR™, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.
Taking part in an educational sleep program resulted in a 30-minute average increase in sleep duration at a one-month follow-up for preschoolers, according to a new study from the University of Michigan.
Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.
A study published in the current issue of Family Process provides an in-depth look at fathering in families with young children and finds that the most involved fathers live outside traditional gendered roles.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437383510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 027736 (Connecticut) | Primary |
| Provider Name | Dennis J Kobylarz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1003813965 PECOS PAC ID: 6507890845 Enrollment ID: I20090922000422 |
News Archive
The seventh meeting in the "Emergence and Convergence" series jointly organized by La Fondation IPSEN and Nature brings together today in San Antonio (Texas, USA) leading experts to discuss concepts emerging from gene regulation studies in immune cells that have led to insights into the initiation and maintenance of epigenetic chromatin marks necessary for proper differentiation and function of these cells in the immune system.
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIR™. Kiadis Pharma's lead program, ATIR™, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.
Taking part in an educational sleep program resulted in a 30-minute average increase in sleep duration at a one-month follow-up for preschoolers, according to a new study from the University of Michigan.
Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.
A study published in the current issue of Family Process provides an in-depth look at fathering in families with young children and finds that the most involved fathers live outside traditional gendered roles.
› Verified 2 days ago
News Archive
The seventh meeting in the "Emergence and Convergence" series jointly organized by La Fondation IPSEN and Nature brings together today in San Antonio (Texas, USA) leading experts to discuss concepts emerging from gene regulation studies in immune cells that have led to insights into the initiation and maintenance of epigenetic chromatin marks necessary for proper differentiation and function of these cells in the immune system.
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIR™. Kiadis Pharma's lead program, ATIR™, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.
Taking part in an educational sleep program resulted in a 30-minute average increase in sleep duration at a one-month follow-up for preschoolers, according to a new study from the University of Michigan.
Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.
A study published in the current issue of Family Process provides an in-depth look at fathering in families with young children and finds that the most involved fathers live outside traditional gendered roles.
› Verified 2 days ago